Zobrazeno 241 - 250
of 1 657 363
pro vyhledávání: '"358"'
Autor:
Юрий Викторович Лучинский
Publikováno v:
Izvestiâ Ûžnogo Federalʹnogo Universiteta: Filologičeskie Nauki, Iss 4 (2016)
Цитировать: Лучинский Ю.В. Ахмадулин Е.В. Основы теории журналистики: 2-е изд., испр. и доп.: учебник и практикум для академического бакалав
Externí odkaz:
https://doaj.org/article/582dd57db9144f5187ff245a9fc64069
Autor:
Santana-Davila, Rafael, Holtan, Shernan G., Dewald, Gordon W., Ketterling, Rhett P., Knudson, Ryan A., Hanson, Curtis A., Steensma, David P., Tefferi, Ayalew
Publikováno v:
In Leukemia Research 2008 32(3):407-411
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Huang LL; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Hu XS; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Wang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Li JL; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Wang HY; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Liu P; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Xu JP; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., He XH; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Hao XZ; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Jiang PD; Department of VIP Medical, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Liu YT; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Luo J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Zhou SY; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Wang JW; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Yang JL; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Qin Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Yuan P; Department of VIP Medical, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Lin L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China., Shi YK; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China.
Publikováno v:
Thoracic cancer [Thorac Cancer] 2021 Jul; Vol. 12 (13), pp. 1943-1951. Date of Electronic Publication: 2021 May 09.
Autor:
Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA ferrisrl@upmc.edu., Spanos WC; Sanford Cancer Center, Sanford Health, Sioux Falls, South Dakota, USA., Leidner R; Providence Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Martens UM; SLK-Clinics, MOLIT Institute, Heilbronn, Germany., Kyi C; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sharfman W; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Chung CH; Department of Head and Neck-Endocrine Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Cancer Center, Utrecht, The Netherlands., Gauthier H; Department of Medical Oncology, Université de Paris, Saint Louis Hospital, Paris, France., Chiosea SI; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Vujanovic L; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Taube JM; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Stein JE; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Li J; Bristol Myers Squibb, Princeton, New Jersey, USA., Li B; Bristol Myers Squibb, Princeton, New Jersey, USA., Chen T; Bristol Myers Squibb, Princeton, New Jersey, USA., Barrows A; Bristol Myers Squibb, Princeton, New Jersey, USA., Topalian SL; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).
Autor:
Wosiski-Kuhn M; Department of Neurobiology and Anatomy, Wake Forest School of Medicine, Winston-Salem, NC, USA., Caress JB; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA, and., Cartwright MS; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA, and., Hawkins GA; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA., Milligan C; Department of Neurobiology and Anatomy, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Publikováno v:
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2021 May; Vol. 22 (3-4), pp. 248-259. Date of Electronic Publication: 2020 Sep 14.
Publikováno v:
The Virginia Law Register, 1908 Dec 01. 14(8), 632-634.
Externí odkaz:
https://www.jstor.org/stable/1102410
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nasrifar, Khashayar1 (AUTHOR), Al Abri, Sultan Ghassan1 (AUTHOR)
Publikováno v:
Petroleum Science & Technology. 2021, Vol. 39 Issue 15/16, p564-581. 18p.
Publikováno v:
In Journal of Computational and Applied Mathematics February 2020 365